Project #87: Leveraging circadian biology to enhance the function and the survival of transplanted human stem cell-derived ß-cells for the treatment of T1D
This Diabetes Research Connection grant supports research into how circadian biology can improve the survival and function of transplanted stem cell-derived beta cells for type 1 diabetes therapy.
Funder: Diabetes Research Connection
Due Dates: Rolling (submit anytime)
Funding Amounts: Up to $75,000 per project; typically supports 1-year research projects.
Summary: Supports early-career researchers investigating circadian biology to improve stem cell-derived beta cell therapy for type 1 diabetes.
Key Information: Only early-career scientists are eligible; projects must focus on innovative type 1 diabetes research.
Description
This funding opportunity, administered by the Diabetes Research Connection (DRC), supports early-career researchers exploring how circadian biology can enhance the function and survival of transplanted human stem cell-derived beta cells for treating type 1 diabetes (T1D). The project aims to uncover and manipulate the genes and proteins responsible for the circadian clock in beta cells, with the goal of optimizing their performance post-transplant and advancing the search for a lasting T1D cure. DRC funds innovative, peer-reviewed projects that address prevention, cure, and improved management of T1D.
